Healthcare provider profile · identity verified

John A Desanto

Internal Medicine · FISHERS, IN · NPI 1679596712

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1198	350
Amlodipine Besylate	Amlodipine Besylate	678	220
Levothyroxine Sodium	Levothyroxine Sodium	500	146
Lisinopril	Lisinopril	464	124
Losartan Potassium	Losartan Potassium	365	123
Omeprazole	Omeprazole	353	109
Famotidine	Famotidine	255	52
Rosuvastatin Calcium	Rosuvastatin Calcium	253	91
Fluticasone Propionate	Fluticasone Propionate	233	57
Metoprolol Succinate	Metoprolol Succinate	227	68
Tamsulosin Hcl	Tamsulosin Hcl	225	68
Metformin Hcl	Metformin Hcl	224	57
Hydrochlorothiazide	Hydrochlorothiazide	223	73
Metformin Hcl Er	Metformin Hcl	212	76
Pantoprazole Sodium	Pantoprazole Sodium	205	68
Alendronate Sodium	Alendronate Sodium	194	58
Simvastatin	Simvastatin	185	51
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	155	155
Gabapentin	Gabapentin	154	61
Ezetimibe	Ezetimibe	153	54
Sertraline Hcl	Sertraline Hcl	147	40
Trazodone Hcl	Trazodone Hcl	144	50
Escitalopram Oxalate	Escitalopram Oxalate	143	44
Carvedilol	Carvedilol	140	51
Hydralazine Hcl	Hydralazine Hcl	134	41
Metoprolol Tartrate	Metoprolol Tartrate	128	38
Jardiance	Empagliflozin	125	35
Furosemide	Furosemide	118	48
Pravastatin Sodium	Pravastatin Sodium	117	39
Albuterol Sulfate Hfa	Albuterol Sulfate	116	50
Allopurinol	Allopurinol	115	32
Montelukast Sodium	Montelukast Sodium	115	34
Duloxetine Hcl	Duloxetine Hcl	113	34
Buspirone Hcl	Buspirone Hcl	91	27
Mounjaro	Tirzepatide	86	17
Potassium Chloride	Potassium Chloride	85	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	80	21
Fluoxetine Hcl	Fluoxetine Hcl	79	24
Bupropion Xl	Bupropion Hcl	78	24
Donepezil Hcl	Donepezil Hcl	75	15
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	73	15
Tramadol Hcl	Tramadol Hcl	72	22
Finasteride	Finasteride	64	13
Citalopram Hbr	Citalopram Hydrobromide	62	23
Eliquis	Apixaban	62	23
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	60	18
Ozempic	Semaglutide	59	15
Cephalexin	Cephalexin	58	40
Clopidogrel	Clopidogrel Bisulfate	55	23
Spironolactone	Spironolactone	54	19
Myrbetriq	Mirabegron	53	13
Nifedipine Er	Nifedipine	51	17
Glipizide Er	Glipizide	50	19
Trulicity	Dulaglutide	50	12
Propranolol Hcl	Propranolol Hcl	48	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	46	18
Atenolol	Atenolol	44	19
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	43	11
Triamcinolone Acetonide	Triamcinolone Acetonide	43	12
Doxycycline Hyclate	Doxycycline Hyclate	42	28
Januvia	Sitagliptin Phosphate	42	suppressed
Mirtazapine	Mirtazapine	41	17
Shingrix	Varicella-Zoster Ge/As01b/Pf	40	34
Warfarin Sodium	Warfarin Sodium	40	13
Doxazosin Mesylate	Doxazosin Mesylate	38	16
Ramipril	Ramipril	37	12
Valsartan	Valsartan	37	15
Esomeprazole Magnesium	Esomeprazole Magnesium	36	11
Lovastatin	Lovastatin	36	suppressed
Primidone	Primidone	36	suppressed
Meloxicam	Meloxicam	35	16
Oxybutynin Chloride Er	Oxybutynin Chloride	33	suppressed
Colchicine	Colchicine	32	suppressed
Hydrocortisone	Hydrocortisone	32	suppressed
Risperidone	Risperidone	31	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	31	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	30	13
Alprazolam	Alprazolam	29	suppressed
Benazepril Hcl	Benazepril Hcl	28	suppressed
Breo Ellipta	Fluticasone/Vilanterol	28	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	28	suppressed
Ketoconazole	Ketoconazole	28	11
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	27	27
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	16
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	27	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	27	11
Chlorthalidone	Chlorthalidone	26	13
Nitroglycerin	Nitroglycerin	26	15
Prednisone	Prednisone	26	19
Vascepa	Icosapent Ethyl	26	suppressed
Pregabalin	Pregabalin	25	suppressed
Arnuity Ellipta	Fluticasone Furoate	24	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	23	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	22	suppressed
Clotrimazole	Clotrimazole	22	suppressed
Glimepiride	Glimepiride	22	suppressed
Klor-Con M20	Potassium Chloride	22	suppressed
Memantine Hcl	Memantine Hcl	22	suppressed
Synthroid	Levothyroxine Sodium	22	11
Tradjenta	Linagliptin	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Azelastine Hcl	Azelastine Hcl	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Lorazepam	Lorazepam	19	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Lansoprazole	Lansoprazole	18	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	11
Scopolamine	Scopolamine	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	16
Ammonium Lactate	Ammonium Lactate	15	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	15	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	15	suppressed
Diazepam	Diazepam	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Repatha Sureclick	Evolocumab	15	suppressed
Trandolapril	Trandolapril	15	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	14
Carbamazepine	Carbamazepine	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Albuterol Sulfate	Albuterol Sulfate	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Linzess	Linaclotide	13	suppressed
Microgestin	Norethindrone Ac/Eth Estradiol	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	13	suppressed
Sulfasalazine Dr	Sulfasalazine	13	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	12	suppressed
Methylprednisolone	Methylprednisolone	12	11
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Testosterone	Testosterone	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Varenicline Tartrate	Varenicline Tartrate	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Fluconazole	Fluconazole	11	suppressed
Glyxambi	Empagliflozin/Linagliptin	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Minocycline Hcl	Minocycline Hcl	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Nystatin	Nystatin	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Torsemide	Torsemide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error